MoneyWorks4Me

Concord Drugs informs about standalone financial results

14 Nov 2016 Evaluate

Concord Drugs has informed about Standalone Financial Results, Limited Review Report for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..